News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
694,516 Results
Type
Article (39466)
Company Profile (247)
Press Release (654803)
Section
Business (204069)
Career Advice (2006)
Deals (35412)
Drug Delivery (93)
Drug Development (80976)
Employer Resources (170)
FDA (16145)
Job Trends (14836)
News (344962)
Policy (32484)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (7)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (17)
2024 Biotech Beach Digital (8)
2024 Biotech Beach Standard (4)
2024 Genetown Digital (5)
2024 Genetown Standard (9)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (5)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Standard (1)
Academia (2544)
Accelerated approval (2)
Adcomms (20)
Allergies (78)
Alliances (49347)
ALS (79)
Alzheimer's disease (1330)
Antibody-drug conjugate (ADC) (99)
Approvals (16130)
Artificial intelligence (217)
Autoimmune disease (11)
Automation (14)
Bankruptcy (359)
Best Places to Work (11636)
BIOSECURE Act (18)
Biosimilars (95)
Biotechnology (175)
Bladder cancer (50)
Brain cancer (24)
Breast cancer (238)
Cancer (1831)
Cardiovascular disease (139)
Career advice (1671)
Career pathing (28)
CAR-T (132)
Cell therapy (379)
Cervical cancer (14)
Clinical research (65485)
Collaboration (719)
Compensation (418)
Complete response letters (18)
COVID-19 (2575)
CRISPR (34)
C-suite (189)
Cystic fibrosis (97)
Data (1772)
Decentralized trials (2)
Denatured (15)
Depression (36)
Diabetes (227)
Diagnostics (6307)
Digital health (17)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (107)
Drug pricing (94)
Drug shortages (25)
Duchenne muscular dystrophy (70)
Earnings (85851)
Editorial (30)
Employer branding (21)
Employer resources (146)
Events (111329)
Executive appointments (607)
FDA (17143)
Featured Employer (48)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (6)
Funding (644)
Gene editing (91)
Generative AI (18)
Gene therapy (263)
GLP-1 (665)
Government (4370)
Grass and pollen (4)
Guidances (47)
Healthcare (18792)
Huntington's disease (22)
IgA nephropathy (20)
Immunology and inflammation (92)
Indications (24)
Infectious disease (2696)
Inflammatory bowel disease (128)
Inflation Reduction Act (8)
Influenza (43)
Intellectual property (72)
Interviews (311)
IPO (16480)
IRA (40)
Job creations (3628)
Job search strategy (1421)
Kidney cancer (9)
Labor market (30)
Layoffs (442)
Leadership (14)
Legal (7895)
Liver cancer (70)
Lung cancer (267)
Lymphoma (123)
Machine learning (2)
Management (58)
Manufacturing (253)
MASH (57)
Medical device (13293)
Medtech (13298)
Mergers & acquisitions (19360)
Metabolic disorders (594)
Multiple sclerosis (62)
NASH (16)
Neurodegenerative disease (70)
Neuropsychiatric disorders (23)
Neuroscience (1774)
NextGen: Class of 2025 (6510)
Non-profit (4476)
Northern California (2263)
Now hiring (36)
Obesity (328)
Opinion (197)
Ovarian cancer (61)
Pain (71)
Pancreatic cancer (72)
Parkinson's disease (124)
Partnered (17)
Patents (185)
Patient recruitment (85)
Peanut (45)
People (56967)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20392)
Phase II (28839)
Phase III (21485)
Pipeline (839)
Podcasts (41)
Policy (103)
Postmarket research (2563)
Preclinical (8602)
Press Release (64)
Prostate cancer (86)
Psychedelics (30)
Radiopharmaceuticals (243)
Rare diseases (343)
Real estate (5899)
Recruiting (65)
Regulatory (22030)
Reports (43)
Research institute (2315)
Resumes & cover letters (349)
Rett syndrome (3)
RNA editing (2)
RSV (37)
Schizophrenia (61)
Series A (114)
Series B (69)
Service/supplier (11)
Sickle cell disease (49)
Southern California (1955)
Special edition (14)
Sponsored (28)
Startups (3569)
State (2)
Stomach cancer (12)
Supply chain (58)
The Weekly (25)
United States (19972)
Vaccines (639)
Venture capitalists (35)
Webinars (12)
Weight loss (220)
Women's health (31)
Worklife (14)
Date
Today (115)
Last 7 days (613)
Last 30 days (2982)
Last 365 days (33965)
2025 (6414)
2024 (35217)
2023 (40076)
2022 (51173)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32109)
2016 (31480)
2015 (37553)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (717)
Alabama (48)
Alaska (7)
Arizona (215)
Arkansas (12)
Asia (37597)
Australia (6147)
California (5184)
Canada (1799)
China (423)
Colorado (237)
Connecticut (250)
Delaware (118)
Europe (80620)
Florida (771)
Georgia (181)
Idaho (57)
Illinois (468)
India (22)
Indiana (281)
Iowa (7)
Japan (130)
Kansas (99)
Kentucky (23)
Louisiana (7)
Maine (60)
Maryland (795)
Massachusetts (3927)
Michigan (205)
Minnesota (353)
Mississippi (2)
Missouri (73)
Montana (27)
Nebraska (25)
Nevada (54)
New Hampshire (62)
New Jersey (1477)
New Mexico (28)
New York (1485)
North Carolina (882)
North Dakota (7)
Northern California (2263)
Ohio (181)
Oklahoma (13)
Oregon (33)
Pennsylvania (1181)
Puerto Rico (7)
Rhode Island (24)
South America (1093)
South Carolina (16)
South Dakota (1)
Southern California (1955)
Tennessee (87)
Texas (765)
Utah (160)
Virginia (121)
Washington D.C. (56)
Washington State (494)
West Virginia (3)
Wisconsin (47)
694,516 Results for "cutera inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Cutera, Inc. Reports Inducement Grants as Permitted by the Nasdaq Listing Rules
Cutera, Inc. granted a total of 44,500 non-qualified inducement stock options to six employees.
May 30, 2024
·
1 min read
Business
Cutera Announces First Quarter 2024 Financial Results
Cutera, Inc., a leading provider of aesthetic and dermatology solutions, reported financial results for the first quarter ended March 31, 2024.
May 9, 2024
·
17 min read
Business
Cutera to Announce First Quarter Results on May 9, 2024
Cutera, Inc. today announced that it will report financial results for the first quarter ended March 31, 2024, after the market close on Thursday, May 9, 2024.
April 26, 2024
·
1 min read
Biotech Beach
Cutera® Announces the North America Launch of xeo®+
Cutera, Inc. (Nasdaq: CUTR), a leading provider of aesthetic and dermatology solutions, today announces the launch of xeo+, a pioneering laser and light-based multi-application platform built on a rich history of excellence in performance and innovation.
April 11, 2024
·
3 min read
Biotech Bay
Cutera, Inc. Announces Preliminary Unaudited Financial Results for Full-Year 2023
Cutera, Inc., a leading provider of aesthetic and dermatology solutions, announced certain preliminary, unaudited financial results for the year ended December 31, 2023.
January 9, 2024
·
4 min read
Business
Cutera, Inc. to Announce Third Quarter Results on November 8, 2023
Cutera, Inc. (Nasdaq: CUTR) (“Cutera” or the “Company”), a leading provider of aesthetic and dermatology solutions, today announced that it will report financial results for the third quarter of 2023 after the market close on Wednesday, November 8, 2023.
October 25, 2023
·
1 min read
Biotech Bay
Cutera, Inc. Reports Inducement Grants as permitted by the Nasdaq Listing Rules - November 16, 2023
Cutera, Inc., a leading provider of aesthetic and dermatology solutions, announced that Stephana Patton, who joined Cutera on November 13, 2023, as the Chief Legal Officer will receive a grant of inducement awards.
November 16, 2023
·
1 min read
Business
Cutera, Inc. Appoints Brent Hauser as President, International
Cutera, Inc. is pleased to announce the appointment of Brent Hauser as President, International, effective October 2, 2023.
October 2, 2023
·
3 min read
Biotech Bay
Cutera, Inc. to Participate in Upcoming Investor Conferences - November 10, 2023
Cutera, Inc. announced that Taylor Harris, Chief Executive Office, and Greg Barker, Vice President of Corporate FP&A and Investor Relations, will participate in Fireside Chats at the following upcoming investor conferences
November 10, 2023
·
1 min read
Business
Cutera to Announce Fourth Quarter and Full-Year 2023 Results on March 21, 2024
Cutera, Inc. today announced that it will report financial results for the fourth quarter and full year ended December 31, 2023 after the market close on Thursday, March 21, 2024.
March 1, 2024
·
4 min read
1 of 69,452
Next
